These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32795402)

  • 1. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
    Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
    Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
    Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
    Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
    Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
    Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation.
    Yamasaki T; Nishiyama A; Kurogi N; Nishimura K; Nishida S; Kurotaki D; Ban T; Ramilowski JA; Ozato K; Toyoda A; Tamura T
    Cell Rep; 2024 Apr; 43(4):114107. PubMed ID: 38613785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomy of a superenhancer.
    Kim S; Liu TT; Ou F; Murphy TL; Murphy KM
    Adv Immunol; 2024; 163():51-96. PubMed ID: 39271259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BATF-JUN is critical for IRF4-mediated transcription in T cells.
    Li P; Spolski R; Liao W; Wang L; Murphy TL; Murphy KM; Leonard WJ
    Nature; 2012 Oct; 490(7421):543-6. PubMed ID: 22992523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
    Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.
    Glasmacher E; Agrawal S; Chang AB; Murphy TL; Zeng W; Vander Lugt B; Khan AA; Ciofani M; Spooner CJ; Rutz S; Hackney J; Nurieva R; Escalante CR; Ouyang W; Littman DR; Murphy KM; Singh H
    Science; 2012 Nov; 338(6109):975-80. PubMed ID: 22983707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
    Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
    J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development.
    Yamamoto M; Kato T; Hotta C; Nishiyama A; Kurotaki D; Yoshinari M; Takami M; Ichino M; Nakazawa M; Matsuyama T; Kamijo R; Kitagawa S; Ozato K; Tamura T
    PLoS One; 2011; 6(10):e25812. PubMed ID: 22003407
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
    Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who on IRF are you? IRF8 deficiency redirects cDC1 lineage commitment.
    Waller K; Scott CL
    Trends Immunol; 2022 Sep; 43(9):687-689. PubMed ID: 35963772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiling of BATF family proteins/JUNB/IRF hetero-trimers using Spec-seq.
    Chang YK; Zuo Z; Stormo GD
    BMC Mol Biol; 2018 Mar; 19(1):5. PubMed ID: 29587652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger-IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell.
    Ochiai K; Kondo H; Okamura Y; Shima H; Kurokochi Y; Kimura K; Funayama R; Nagashima T; Nakayama K; Yui K; Kinoshita K; Igarashi K
    Blood Adv; 2018 Apr; 2(8):883-894. PubMed ID: 29669755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
    Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
    Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular choreography of IRF4 and IRF8 with immune system partners.
    Singh H; Glasmacher E; Chang AB; Vander Lugt B
    Cold Spring Harb Symp Quant Biol; 2013; 78():101-4. PubMed ID: 24752218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
    Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional reprogramming by mutated IRF4 in lymphoma.
    Schleussner N; Cauchy P; Franke V; Giefing M; Fornes O; Vankadari N; Assi SA; Costanza M; Weniger MA; Akalin A; Anagnostopoulos I; Bukur T; Casarotto MG; Damm F; Daumke O; Edginton-White B; Gebhardt JCM; Grau M; Grunwald S; Hansmann ML; Hartmann S; Huber L; Kärgel E; Lusatis S; Noerenberg D; Obier N; Pannicke U; Fischer A; Reisser A; Rosenwald A; Schwarz K; Sundararaj S; Weilemann A; Winkler W; Xu W; Lenz G; Rajewsky K; Wasserman WW; Cockerill PN; Scheidereit C; Siebert R; Küppers R; Grosschedl R; Janz M; Bonifer C; Mathas S
    Nat Commun; 2023 Nov; 14(1):6947. PubMed ID: 37935654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.